谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Transfusion requirements in adult patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibitors receiving Ravulizumab or Eculizumab: results from a phase 3 non-inferiority study

A. Roeth,A. Risitano,J. H. Jang, G. -W. Lee,W. Wanachiwanawin,H. Schrezenmeier,Y. Yonemura,T. Munir,R. Pavani,R. Aguzzi,L. Shafner,A. Kulagin,Sicre F. de Fontbrune

ONCOLOGY RESEARCH AND TREATMENT（2019）

引用 0|浏览24
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要